New Zealand - English - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - teriparatide 250 µg/ml (rhpth(1-34));   - solution for injection - 250 mcg/ml - active: teriparatide 250 µg/ml (rhpth(1-34))   excipient: glacial acetic acid hydrochloric acid mannitol metacresol sodium acetate sodium hydroxide water for injection - forteo, in combination with calcium and vitamin d, is indicated for the treatment of osteoporosis in postmenopausal women and in men at high risk of fracture.

United States - English - NLM (National Library of Medicine)

covis pharma us, inc - nisoldipine (unii: 4i8hab65sz) (nisoldipine - unii:4i8hab65sz) - nisoldipine 8.5 mg - sular is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents. sular is contraindicated in patients with known hypersensitivity to dihydropyridine calcium channel blockers.

United States - English - NLM (National Library of Medicine)

shionogi inc. - nisoldipine (unii: 4i8hab65sz) (nisoldipine - unii:4i8hab65sz) - nisoldipine 8.5 mg - sular is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents. sular is contraindicated in patients with known hypersensitivity to dihydropyridine calcium channel blockers.

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - nisoldipine (unii: 4i8hab65sz) (nisoldipine - unii:4i8hab65sz) - nisoldipine 25.5 mg - sular is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents. sular is contraindicated in patients with known hypersensitivity to dihydropyridine calcium channel blockers.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - nisoldipine - modified-release tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - nisoldipine - modified-release tablet - 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - nisoldipine - modified-release tablet - 30mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - rifampicin - powder and solvent for solution for infusion - 600mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - itraconazole - solution for infusion - 10mg/1ml

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - phenytoin sodium 50 mg/ml - solution for injection - 50 mg/ml - active: phenytoin sodium 50 mg/ml excipient: ethanol propylene glycol sodium hydroxide water for injection